Latest filing published 21 Sept 2023 for Paratek Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Randall B. Brenner: trading record in brief
This profile gathers the share dealings of Randall B. Brenner in Paratek Pharmaceuticals, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 3 October 2019 to 21 September 2023, the count stands at 31 filings.
On the market, this insider has only sold: 18 sales, €623k in total. Outside the open market, there are 11 share grants. So far in 2023, the count stands at no purchases and 1 sale.
Most recently, on 21 September 2023, the filings show a transaction in Paratek Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Randall B. Brenner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 329,709 sharesCommon StockSEC:0000899243-23-019365:0
- 67,500 shares0Common StockSEC:0000904454-23-000478:0
- 15,000 shares0Common StockSEC:0000904454-22-000649:0
- 11,105 shares@ US$1.9830.7% of flowCommon StockSEC:0000904454-22-000623:0
- 3,516 shares@ US$3.4718.0% of flowCommon StockSEC:0000904454-22-000528:0
- 8,500 shares0Common StockSEC:0000904454-22-000506:0
- 47,727 shares0Common StockSEC:0000904454-22-000425:0
- 67,500 shares0Common StockSEC:0000904454-22-000264:0
- 4,479 shares@ US$4.4234.6% of flowCommon StockSEC:0000904454-21-000844:0
- 21,250 shares0Common StockSEC:0000904454-21-000624:0
- 28,636 shares0Common StockSEC:0000904454-21-000516:0
11 of 11 declarations
